BRIAN CONCANNON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRIAN CONCANNON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRIAN CONCANNON. BRIAN CONCANNON is Director in CONMED CORP ($CNMD) and Chief Operating Officer in HAEMONETICS CORP ($HAE) and President & CEO in HAEMONETICS CORP ($HAE) and President & CEO in HAEMONETICS CORP ($HAE) and President, Patient Division in HAEMONETICS CORP ($HAE).
Latest Insider Trading Transactions of BRIAN CONCANNON
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 118,798 | 115.8 K to 118.8 K (+2.59 %) |
May 02 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 13.05 | 3,000 | 39,158 | 27,000 | |
May 02 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 40,000 | |
May 02 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 38.67 | 10,000 | 386,742 | 115,798 | 125.8 K to 115.8 K (-7.95 %) |
May 02 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 125,798 | 115.8 K to 125.8 K (+8.64 %) |
May 02 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 38.62 | 3,000 | 115,862 | 115,798 | 118.8 K to 115.8 K (-2.53 %) |
May 02 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 118,798 | 115.8 K to 118.8 K (+2.59 %) |
Apr 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 41.83 | 488 | 20,413 | 115,798 | 116.3 K to 115.8 K (-0.42 %) |
Apr 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 26.38 | 288 | 7,597 | 0 | |
Apr 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 50,000 | |
Apr 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.94 | 10,000 | 419,393 | 116,286 | 126.3 K to 116.3 K (-7.92 %) |
Apr 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 126,286 | 116.3 K to 126.3 K (+8.60 %) |
Apr 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.94 | 288 | 12,079 | 116,286 | 116.6 K to 116.3 K (-0.25 %) |
Apr 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 26.38 | 288 | 7,597 | 116,574 | 116.3 K to 116.6 K (+0.25 %) |
Mar 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 26.38 | 3,000 | 79,140 | 288 | |
Mar 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 60,000 | |
Mar 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.06 | 10,000 | 410,624 | 116,286 | 126.3 K to 116.3 K (-7.92 %) |
Mar 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 126,286 | 116.3 K to 126.3 K (+8.60 %) |
Mar 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.06 | 3,000 | 123,187 | 116,286 | 119.3 K to 116.3 K (-2.51 %) |
Mar 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 26.38 | 3,000 | 79,140 | 119,286 | 116.3 K to 119.3 K (+2.58 %) |
Feb 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 26.38 | 3,000 | 79,140 | 3,288 | |
Feb 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 70,000 | |
Feb 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.96 | 10,000 | 419,589 | 116,286 | 126.3 K to 116.3 K (-7.92 %) |
Feb 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 126,286 | 116.3 K to 126.3 K (+8.60 %) |
Feb 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.96 | 3,000 | 125,877 | 116,286 | 119.3 K to 116.3 K (-2.51 %) |
Feb 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 26.38 | 3,000 | 79,140 | 119,286 | 116.3 K to 119.3 K (+2.58 %) |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 26.38 | 3,000 | 79,140 | 6,288 | |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 80,000 | |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.47 | 10,000 | 414,748 | 116,286 | 126.3 K to 116.3 K (-7.92 %) |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 126,286 | 116.3 K to 126.3 K (+8.60 %) |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.47 | 3,000 | 124,424 | 116,286 | 119.3 K to 116.3 K (-2.51 %) |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 26.38 | 3,000 | 79,140 | 119,286 | 116.3 K to 119.3 K (+2.58 %) |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 26.38 | 3,000 | 79,140 | 6,288 | |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 80,000 | |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.47 | 10,000 | 414,748 | 116,286 | 126.3 K to 116.3 K (-7.92 %) |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 126,286 | 116.3 K to 126.3 K (+8.60 %) |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.47 | 3,000 | 124,424 | 116,286 | 119.3 K to 116.3 K (-2.51 %) |
Jan 08 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 26.38 | 3,000 | 79,140 | 119,286 | 116.3 K to 119.3 K (+2.58 %) |
Dec 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 26.38 | 3,000 | 79,140 | 9,288 | |
Dec 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 90,000 | |
Dec 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 40.75 | 10,000 | 407,491 | 116,286 | 126.3 K to 116.3 K (-7.92 %) |
Dec 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 126,286 | 116.3 K to 126.3 K (+8.60 %) |
Dec 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 40.75 | 3,000 | 122,247 | 116,286 | 119.3 K to 116.3 K (-2.51 %) |
Dec 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 26.38 | 3,000 | 79,140 | 119,286 | 116.3 K to 119.3 K (+2.58 %) |
Nov 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 6,144 | |
Nov 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 5,000 | 113,175 | 50,000 | |
Nov 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 81.82 | 1,500 | 122,737 | 58,143 | 59.6 K to 58.1 K (-2.51 %) |
Nov 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 59,643 | 58.1 K to 59.6 K (+2.58 %) |
Nov 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 81.82 | 5,000 | 409,123 | 58,143 | 63.1 K to 58.1 K (-7.92 %) |
Nov 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 5,000 | 113,175 | 63,143 | 58.1 K to 63.1 K (+8.60 %) |
Nov 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 76.33 | 534 | 40,762 | 58,143 | 58.7 K to 58.1 K (-0.91 %) |
Nov 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 76.33 | 1,463 | 111,675 | 58,677 | 60.1 K to 58.7 K (-2.43 %) |
Oct 30 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 78.51 | 1,284 | 100,807 | 60,140 | 61.4 K to 60.1 K (-2.09 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | A | 78.11 | 125,191 | 9,778,669 | 125,191 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Grant | A | 0.00 | 13,442 | 0 | 61,424 | 48 K to 61.4 K (+28.01 %) |
Oct 25 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 78.04 | 189 | 14,749 | 47,982 | 48.2 K to 48 K (-0.39 %) |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 7,644 | |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 5,000 | 113,175 | 55,000 | |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 80.73 | 5,000 | 403,631 | 48,171 | 53.2 K to 48.2 K (-9.40 %) |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 5,000 | 113,175 | 53,171 | 48.2 K to 53.2 K (+10.38 %) |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 80.73 | 1,500 | 121,089 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 9,144 | |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 5,000 | 113,175 | 60,000 | |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 73.67 | 5,000 | 368,374 | 48,171 | 53.2 K to 48.2 K (-9.40 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 5,000 | 113,175 | 53,171 | 48.2 K to 53.2 K (+10.38 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 73.70 | 1,500 | 110,550 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 10,644 | |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 5,000 | 113,175 | 65,000 | |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 71.68 | 5,000 | 358,425 | 48,171 | 53.2 K to 48.2 K (-9.40 %) |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 5,000 | 113,175 | 53,171 | 48.2 K to 53.2 K (+10.38 %) |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 71.92 | 1,500 | 107,876 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 12,144 | |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 70,000 | |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 74.02 | 3,000 | 222,048 | 48,171 | 51.2 K to 48.2 K (-5.86 %) |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,171 | 48.2 K to 51.2 K (+6.23 %) |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 74.01 | 1,500 | 111,015 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 13,644 | |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 73,000 | |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 68.47 | 3,000 | 205,412 | 48,171 | 51.2 K to 48.2 K (-5.86 %) |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,171 | 48.2 K to 51.2 K (+6.23 %) |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 68.59 | 1,500 | 102,882 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
May 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 15,144 | |
May 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 2,000 | 82,300 | 0 | |
May 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 76,000 | |
May 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 71.71 | 3,000 | 215,143 | 48,171 | 51.2 K to 48.2 K (-5.86 %) |
May 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,171 | 48.2 K to 51.2 K (+6.23 %) |
May 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 71.79 | 2,000 | 143,586 | 48,171 | 50.2 K to 48.2 K (-3.99 %) |
May 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 2,000 | 82,300 | 50,171 | 48.2 K to 50.2 K (+4.15 %) |
May 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 71.63 | 1,500 | 107,439 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
May 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Apr 09 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 69.69 | 167 | 11,638 | 48,171 | 48.3 K to 48.2 K (-0.35 %) |
Apr 04 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 2,000 | 82,300 | 2,000 | |
Apr 04 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 79,000 | |
Apr 04 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 69.81 | 3,000 | 209,426 | 48,338 | 51.3 K to 48.3 K (-5.84 %) |
Apr 04 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,338 | 48.3 K to 51.3 K (+6.21 %) |
Apr 04 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 69.76 | 2,000 | 139,521 | 48,338 | 50.3 K to 48.3 K (-3.97 %) |
Apr 04 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 2,000 | 82,300 | 50,338 | 48.3 K to 50.3 K (+4.14 %) |
Mar 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 2,000 | 82,300 | 4,000 | |
Mar 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 82,000 | |
Mar 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 65.80 | 3,000 | 197,400 | 48,338 | 51.3 K to 48.3 K (-5.84 %) |
Mar 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,338 | 48.3 K to 51.3 K (+6.21 %) |
Mar 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 65.80 | 2,000 | 131,600 | 48,338 | 50.3 K to 48.3 K (-3.97 %) |
Mar 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 2,000 | 82,300 | 50,338 | 48.3 K to 50.3 K (+4.14 %) |
Feb 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 2,000 | 82,300 | 6,000 | |
Feb 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 85,000 | |
Feb 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 65.06 | 3,000 | 195,180 | 48,338 | 51.3 K to 48.3 K (-5.84 %) |
Feb 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,338 | 48.3 K to 51.3 K (+6.21 %) |
Feb 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 65.06 | 2,000 | 130,120 | 48,338 | 50.3 K to 48.3 K (-3.97 %) |
Feb 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 2,000 | 82,300 | 50,338 | 48.3 K to 50.3 K (+4.14 %) |
Jan 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 2,000 | 82,300 | 8,000 | |
Jan 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 88,000 | |
Jan 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 62.49 | 3,000 | 187,463 | 48,338 | 51.3 K to 48.3 K (-5.84 %) |
Jan 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,338 | 48.3 K to 51.3 K (+6.21 %) |
Jan 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 62.49 | 2,000 | 124,976 | 48,338 | 50.3 K to 48.3 K (-3.97 %) |
Jan 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 2,000 | 82,300 | 50,338 | 48.3 K to 50.3 K (+4.14 %) |
Dec 05 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 2,000 | 82,300 | 10,000 | |
Dec 05 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 91,000 | |
Dec 05 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 58.76 | 3,000 | 176,280 | 48,338 | 51.3 K to 48.3 K (-5.84 %) |
Dec 05 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,338 | 48.3 K to 51.3 K (+6.21 %) |
Dec 05 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 58.76 | 2,000 | 117,520 | 48,338 | 50.3 K to 48.3 K (-3.97 %) |
Dec 05 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 2,000 | 82,300 | 50,338 | 48.3 K to 50.3 K (+4.14 %) |
Nov 07 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 59.16 | 424 | 25,084 | 48,338 | 48.8 K to 48.3 K (-0.87 %) |
Nov 07 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 59.03 | 1,152 | 68,005 | 48,762 | 49.9 K to 48.8 K (-2.31 %) |
Nov 03 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 2,000 | 82,300 | 12,000 | |
Nov 03 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 94,000 | |
Nov 03 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 57.70 | 3,000 | 173,100 | 49,914 | 52.9 K to 49.9 K (-5.67 %) |
Nov 03 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 52,914 | 49.9 K to 52.9 K (+6.01 %) |
Nov 03 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 57.70 | 2,000 | 115,400 | 49,914 | 51.9 K to 49.9 K (-3.85 %) |
Nov 03 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 2,000 | 82,300 | 51,914 | 49.9 K to 51.9 K (+4.01 %) |
Oct 27 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | A | 61.34 | 109,786 | 6,734,273 | 109,786 | |
Oct 27 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Grant | A | 0.01 | 12,224 | 122 | 49,912 | 37.7 K to 49.9 K (+32.43 %) |
Oct 26 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 61.03 | 115 | 7,018 | 37,688 | 37.8 K to 37.7 K (-0.30 %) |
Oct 26 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 60.41 | 143 | 8,639 | 37,803 | 37.9 K to 37.8 K (-0.38 %) |
Oct 19 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 2,000 | 82,300 | 14,000 | |
Oct 19 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 97,000 | |
Oct 19 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 59.16 | 3,000 | 177,470 | 37,946 | 40.9 K to 37.9 K (-7.33 %) |
Oct 19 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 40,946 | 37.9 K to 40.9 K (+7.91 %) |
Oct 19 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 59.16 | 2,000 | 118,313 | 37,946 | 39.9 K to 37.9 K (-5.01 %) |
Oct 19 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 2,000 | 82,300 | 39,946 | 37.9 K to 39.9 K (+5.27 %) |
Jul 06 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 1,500 | 61,725 | 16,000 | |
Jul 06 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 41.15 | 1,500 | 61,725 | 17,500 | |
Jul 06 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 66.00 | 1,500 | 99,000 | 37,946 | 39.4 K to 37.9 K (-3.80 %) |
Jul 06 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 1,500 | 61,725 | 39,446 | 37.9 K to 39.4 K (+3.95 %) |
Jul 06 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 66.00 | 1,500 | 99,000 | 37,946 | 39.4 K to 37.9 K (-3.80 %) |
Jul 06 2011 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 41.15 | 1,500 | 61,725 | 39,446 | 37.9 K to 39.4 K (+3.95 %) |